CSIR launches India’s first anti diabetic ayurvedic drug BGR -34-Prelims-2016

  • The Council for Scientific and Industrial Research (CSIR) has launched BGR-34, an anti-diabetic ayurvedic drug designed for type 2 Diabetes mellitus. The anti-diabetic ayurvedic drug BGR-34 has been jointly developedby National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plants (CIMAP
  • BGR-34 works by controlling blood sugar and limiting the harmful effects and toxicity of other drugs. It contains 34 identified active phyto-constitutes from herbal resources. It has been economically priced at 5 rupees per tablet as compared to latest DPP4 inhibitors globally.

Leave a Reply